AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
16.21
+0.19 (1.19%)
Mar 2, 2026, 4:00 PM EST - Market closed
AgomAb Therapeutics NV Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for AgomAb Therapeutics NV stock has a target of 28, which predicts a 72.73% increase from the current stock price of 16.21.
Price Target: $28 (+72.73%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for AgomAb Therapeutics NV is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 |
|---|---|
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Initiates $28 | Buy | Initiates | $28 | +72.73% | Mar 3, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.